Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.

about

Proton-pump inhibitors among adults: a nationwide drug-utilization study.

P2860

Q55289788-19BC0A6F-C19C-4B96-AAEF-5B427205A201

P2860

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.

Item

http://www.wikidata.org/entity/Q47742865

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.

@en

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.

@nl

type

Item

label

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.

@en

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.

@nl

prefLabel

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.

@en

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.

@nl

P1476

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.

@en

P2093

Akira Andoh

http://www.w3.org/2001/XMLSchema#string

Kaori Kashiwagi

http://www.w3.org/2001/XMLSchema#string

Ryo Inoue

http://www.w3.org/2001/XMLSchema#string

Tomohisa Takagi

http://www.w3.org/2001/XMLSchema#string

Yuji Naito

http://www.w3.org/2001/XMLSchema#string

P2860

Data, information, knowledge and principle: back to metabolism in KEGG

Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis

Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

Faecalibacterium prausnitzii and human intestinal health

Proton pump inhibitors alter the composition of the gut microbiota

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences

Complications of Proton Pump Inhibitor Therapy.

Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis.

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

P304

195-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000481813

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29316555

http://www.w3.org/2001/XMLSchema#string

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.

about

P2860

P2860

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698